Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Macrophage Activation Marker sCD163 in PBC Patients - Assessment of Treatment Response to UDCA

NCT02931513 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT02931513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02931513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Macrophage Activation Marker sCD163 in PBC Patients - Assessment of Treatment Response to UDCA
Lead sponsor
University of Aarhus
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2016
Completion date
September 30, 2031
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver inflammation, primary biliary cirrhosis, ursodeoxycholic acid